We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGCO icon
6101
RGC Resources
RGCO
$228M
-824
Closed -$21K
RGLS
6102
DELISTED
Regulus Therapeutics
RGLS
-9,187
Closed -$75K
RING icon
6103
iShares MSCI Global Gold Miners ETF
RING
$2.44B
-100
Closed -$3K
RKDA icon
6104
Arcadia Biosciences
RKDA
$1.52M
$0 ﹤0.01%
6
-38
-86% -$3.56K
RMBI icon
6105
Richmond Mutual Bancorp
RMBI
$254M
-702
Closed -$10K
RDNW
6106
RideNow Group
RDNW
$262M
-731
Closed -$30K
RMCO icon
6107
Royalty Management
RMCO
$44.3M
$0 ﹤0.01%
+28
New +$278
RSPS icon
6108
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$247M
-545
Closed -$18K
RSSS icon
6109
Research Solutions
RSSS
$72.2M
-71
Closed
RSVRW
6110
DELISTED
Reservoir Media Inc Warrant
RSVRW
$0 ﹤0.01%
+3
New +$4
RVPH
6111
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
-624
Closed -$61K
RVSB icon
6112
Riverview Bancorp
RVSB
$108M
-2,066
Closed -$15K
RWJ icon
6113
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.1B
-14,454
Closed -$580K
RWO icon
6114
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
-307
Closed -$16K
RWX icon
6115
State Street SPDR Dow Jones International Real Estate ETF
RWX
$270M
$0 ﹤0.01%
4
-20
-83% -$750
SABA
6116
Saba Capital Income & Opportunities Fund II
SABA
$223M
-2,450
Closed -$27K
SABS icon
6117
SAB Biotherapeutics
SABS
$355M
-9
Closed -$1K
SAMG icon
6118
Silvercrest Asset Management
SAMG
$79.9M
$0 ﹤0.01%
1
-1,314
-100% -$20.7K
SANW
6119
DELISTED
S&W Seed Co
SANW
-184
Closed -$13K
SBEV icon
6120
Splash Beverage Group
SBEV
$2.72M
$0 ﹤0.01%
1
SCHA icon
6121
Schwab U.S Small- Cap ETF
SCHA
$23.1B
-34,344
Closed -$894K
SCM icon
6122
Stellus Capital Investment Corp
SCM
$243M
-324
Closed -$4K
SCNI
6123
Scinai Immunotherapeutics
SCNI
$1.27M
$0 ﹤0.01%
+1
New +$257
SCPH
6124
DELISTED
scPharmaceuticals
SCPH
-2,112
Closed -$13K
SCYX icon
6125
SCYNEXIS
SCYX
$52M
-3,266
Closed -$192K

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.